Effect of Small Double-lumen Tube on the Intubation Time of Thoracoscopic Pulmonectomy in Asian Women
Launched by ZHEJIANG CANCER HOSPITAL · Jul 24, 2025
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether using a smaller-sized breathing tube can help doctors place the tube faster during lung surgery in Asian women. When patients have certain lung surgeries, doctors need to insert a special double-lumen tube to help one lung rest while the other works. This study wants to see if choosing a tube one size smaller than usual makes this process quicker without causing breathing problems.
Women between 18 and 80 years old who are having lung surgery and meet certain health criteria may be able to join. Participants will either get the usual tube size or one size smaller during their surgery, and the main thing measured will be how long it takes to put the tube in and get it just right. The study is not recruiting yet, but if you meet the requirements—like having a recent chest scan and no expected breathing difficulties—you might be eligible. This trial could help improve the safety and speed of lung surgeries for Asian women in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients scheduled for thoracoscopic pulmonary resection using a left double-lumen tube under general anesthesia.
- • Patients aged 18-80 years
- • Chest CT scan in our hospital within one month before surgery
- • American Society of Anesthesiologists (ASA) physical status I to III
- Exclusion Criteria:
- • Anticipated difficult airway
- • Patients with tracheal/left main bronchus anomalies
- • Height \<152 cm
- • Refused to participate in the study
About Zhejiang Cancer Hospital
Zhejiang Cancer Hospital is a leading medical institution in China, dedicated to advancing cancer research, treatment, and patient care. As a prominent clinical trial sponsor, the hospital focuses on innovative therapies and evidence-based practices to improve outcomes for cancer patients. With a multidisciplinary team of experienced oncologists and researchers, Zhejiang Cancer Hospital is committed to fostering collaboration and leveraging cutting-edge technology in its clinical trials. The institution aims to contribute significantly to the global understanding of cancer and enhance therapeutic options through rigorous research and development initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported